Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 698 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Berlin, I; Anthenelli, RM
      Monoamine oxidases and tobacco smoking

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Fredriksson, A; Schroder, N; Eriksson, P; Izquierdo, I; Archer, T
      Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits

      PARKINSONISM & RELATED DISORDERS
    3. Vila, M; Jackson-Lewis, V; Guegan, C; Wu, DC; Teismann, P; Choi, DK; Tieu, K; Przedborski, S
      The role of glial cells in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    4. Callizot, N; Guenet, JL; Baillet, C; Warter, JM; Poindron, P
      The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome

      NEUROBIOLOGY OF DISEASE
    5. Ramamoorthy, Y; Tyndale, RF; Sellers, EM
      Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates

      PHARMACOGENETICS
    6. Aguirre, JA; Andbjer, B; Gonzalez-Baron, S; Hansson, A; Stromberg, I; Agnati, LF; Fuxe, K
      Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury

      NEUROREPORT
    7. Smeyne, M; Goloubeva, O; Smeyne, RJ
      Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia

      GLIA
    8. Kalgutkar, AS; Dalvie, DK; Castagnoli, N; Taylor, TJ
      Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors

      CHEMICAL RESEARCH IN TOXICOLOGY
    9. Castagnoli, KP; Steyn, SJ; Petzer, JP; Van der Schyf, CJ; Castagnoli, N
      Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco

      CHEMICAL RESEARCH IN TOXICOLOGY
    10. Mushiroda, T; Ariyoshi, N; Yokoi, T; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      Accumulation of the 1-methyl-4-phenylpyridinium ion in suncus (Suncus murinus) brain: Implication for flavin-containing monooxygenase activity in brain microvessels

      CHEMICAL RESEARCH IN TOXICOLOGY
    11. Kitazawa, M; Anantharam, V; Kanthasamy, AG
      Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptotic cell death in dopaminergic cells

      FREE RADICAL BIOLOGY AND MEDICINE
    12. Fox, SH; Henry, B; Hill, MP; Peggs, D; Crossman, AR; Brotchie, JM
      Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan

      MOVEMENT DISORDERS
    13. Petzinger, GM; Quik, M; Ivashina, E; Jakowec, MW; Jakubiak, M; Di Monte, D; Langston, JW
      Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate

      MOVEMENT DISORDERS
    14. Barlas, O; Hanagasi, HA; Imer, M; Sahin, HA; Sencer, S; Emre, M
      Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism?

      MOVEMENT DISORDERS
    15. Guo, M; Chen, SD; Liu, ZG; Chen, HZ
      Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice

      CHINESE MEDICAL JOURNAL
    16. Su, PC; Ma, YL; Fukuda, M; Mentis, MJ; Tseng, HM; Yen, RF; Liu, HM; Moeller, JR; Eidelberg, D
      Metabolic changes following subthalamotomy for advanced Parkinson's disease

      ANNALS OF NEUROLOGY
    17. Gonzalez-Polo, RA; Mora, A; Clemente, N; Sabio, G; Centeno, F; Soler, G; Fuentes, JM
      Mechanisms of MPP+ incorporation into cerebellar granule cells

      BRAIN RESEARCH BULLETIN
    18. Tariq, M; Khan, HA; Al Moutaery, K; Al Deeb, S
      Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents

      BRAIN RESEARCH BULLETIN
    19. Rothblat, DS; Schroeder, JA; Schneider, JS
      Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism

      JOURNAL OF NEUROSCIENCE RESEARCH
    20. Petroske, E; Meredith, GE; Callen, S; Totterdell, S; Lau, YS
      Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment

      NEUROSCIENCE
    21. Chen, JYR; Hsu, PC; Hsu, IL; Yeh, GC
      Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice

      NEUROSCIENCE LETTERS
    22. Barc, S; Page, G; Barrier, L; Piriou, A; Fauconneau, B
      Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors

      NEUROSCIENCE LETTERS
    23. Araki, T; Muramatsu, Y; Tanaka, K; Matsubara, M; Imai, Y
      Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice

      NEUROSCIENCE LETTERS
    24. Hirata, Y; Kiuchi, K; Nagatsu, T
      Manganese mimics the action of 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in rat striatal tissue slices

      NEUROSCIENCE LETTERS
    25. Obata, T; Kubota, S; Yamanaka, Y
      Allopurinol suppresses para-nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum

      NEUROSCIENCE LETTERS
    26. Marcotte, ER; Chugh, A; Barlas, C; Mishra, RK
      Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57BL/6 mice

      NEUROSCIENCE LETTERS
    27. Genc, S; Kuralay, F; Genc, K; Akhisaroglu, M; Fadiloglu, S; Yorukoglu, K; Fadiloglu, M; Gure, A
      Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

      NEUROSCIENCE LETTERS
    28. Kupsch, A; Sautter, J; Gotz, ME; Breithaupt, W; Schwarz, J; Youdim, MBH; Riederer, P; Gerlach, M; Oertel, WH
      Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

      JOURNAL OF NEURAL TRANSMISSION
    29. Szoko, E; Haberle, D; Halasz, AS; Tekes, K; Magyar, K
      Protective effect of 7-nitroindazole against DSP-4 induced noradrenaline depletion in mouse hippocampus

      JOURNAL OF NEURAL TRANSMISSION
    30. Schmidt, N; Ferger, B
      Neurochemical findings in the MPTP model of Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    31. Klein, BG; Kirby, ML; Freeborn, ER; Bloomquist, JR
      Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    32. Zwart, R; Verhaagh, S; Buitelaar, M; Popp-Snijders, C; Barlow, DP
      Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice

      MOLECULAR AND CELLULAR BIOLOGY
    33. Chen, JF; Xu, K; Petzer, JP; Staal, R; Xu, YH; Beilstein, M; Sonsalla, PK; Castagnoli, K; Castagnoli, N; Schwarzschild, MA
      Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in amodel of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    34. Barc, S; Page, G; Fauconneau, B; Barrier, L; Huguet, F
      A new in vitro approach for investigating the MPTP effect on DA uptake

      NEUROCHEMISTRY INTERNATIONAL
    35. Kumagai, T; Ido, T; Araki, T; Matsubara, M; Imai, Y
      Riluzole protects against MPTP-induced dopamine and DOPAC depletion in mice

      BIOGENIC AMINES
    36. Sedelis, M; Schwarting, RKW; Huston, JP
      Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

      BEHAVIOURAL BRAIN RESEARCH
    37. Chassain, C; Eschalier, A; Durif, F
      Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP

      JOURNAL OF NEUROSCIENCE METHODS
    38. Santiago, M; Machado, A; Cano, J
      Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis

      JOURNAL OF NEUROSCIENCE METHODS
    39. Mazzio, E; Huber, J; Darling, S; Harris, N; Soliman, KFA
      Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells

      NEUROTOXICOLOGY
    40. Lee, ESY; Charlton, CG
      1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    41. Liou, HH; Chen, RC; Chen, THH; Tsai, YF; Tsai, MC
      Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    42. Boyce, S; Rupniak, NMJ; Steventon, MJ; Iversen, SD
      Differential effects of D-1 and D-2 agonists in MPTP,treated primates: Functional implications for Parkinson's disease

      NEUROLOGY
    43. Martel, F; Calhau, C; Soares-da-Silva, P; Azevedo, I
      Transport of [H-3]MPP+ in an immortalized rat brain microvessel endothelial cell line (RBE 4)

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    44. Soto-Otero, R; Mendez-Alvarez, E; Hermida-Ameijeiras, A; Sanchez-Sellero, I; Cruz-Landeira, A; Lamas, MLR
      Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals - Potential implications in relation to oxidative stress

      LIFE SCIENCES
    45. Levites, Y; Weinreb, O; Maor, G; Youdim, MBH; Mandel, S
      Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration

      JOURNAL OF NEUROCHEMISTRY
    46. Grunblatt, E; Mandel, S; Maor, G; Youdim, MBH
      Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine

      JOURNAL OF NEUROCHEMISTRY
    47. Hartmann, A; Michel, PP; Troadec, JD; Mouatt-Prigent, A; Faucheux, BA; Ruberg, M; Agid, Y; Hirsch, EC
      Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neuronsin Parkinson's disease?

      JOURNAL OF NEUROCHEMISTRY
    48. Przedborski, S; Jackson-Lewis, V; Naini, AB; Jakowec, M; Petzinger, G; Miller, R; Akram, M
      The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

      JOURNAL OF NEUROCHEMISTRY
    49. Yoon, KJP; Kode, B; Bowen, L; Redda, KK
      Synthesis of N-(substituted phenylcarbonylamino)-4-ethyl-1,2,3,6-tetrahydropyridines as potential nonsteroidal anti-inflammatory agents

      JOURNAL OF HETEROCYCLIC CHEMISTRY
    50. Henry, B; Fox, SH; Crossman, AR; Brotchie, JM
      mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

      EXPERIMENTAL NEUROLOGY
    51. Steyn, SJ; Castagnoli, K; Steyn, S; Castagnoli, N
      Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels

      EXPERIMENTAL NEUROLOGY
    52. Hofele, K; Sedelis, M; Auburger, GW; Morgan, S; Huston, JP; Schwarting, RKW
      Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility

      EXPERIMENTAL NEUROLOGY
    53. Emborg, ME; Shin, P; Roitberg, B; Sramek, JG; Chu, Y; Stebbins, GT; Hamilton, JS; Suzdak, PD; Steiner, JP; Kordower, JH
      Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys

      EXPERIMENTAL NEUROLOGY
    54. Bocquet, A; Lorent, G; Fuks, B; Grimee, R; Talaga, P; Daliers, J; Klitgaard, H
      Failure of GPI compounds to display neurotrophic activity in vitro and in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    55. Tahar, AH; Ekesbo, A; Gregoire, L; Bangassoro, E; Svensson, KA; Tedroff, J; Bedard, PJ
      Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Quik, M; Di Monte, DA
      Nicotine administration reduces striatal MPP plus levels in mice

      BRAIN RESEARCH
    57. Lipina, SJ; Colombo, JA
      Dissociated functional recovery in parkinsonian monkeys following transplantation of astroglial cells

      BRAIN RESEARCH
    58. Manzana, EJP; Chen, WJA; Champney, TH
      Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels

      BRAIN RESEARCH
    59. Anderson, DW; Neavin, T; Smith, JA; Schneider, JS
      Neuroprotective effects of pramipexole in young and aged MPTP-treated mice

      BRAIN RESEARCH
    60. Wade, TV; Rothblat, DS; Schneider, JS
      Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism

      BRAIN RESEARCH
    61. Gao, XM; Dluzen, DE
      The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

      BRAIN RESEARCH
    62. Tanko, JM; Friedline, R; Suleman, NK; Castagnoli, N
      tert-butoxyl as a model for radicals in biological systems: Caveat emptor

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    63. Ooms, F; Delvosal, S; Wouters, J; Durant, F; Dockendolf, G; Van't Land, C; Glass, T; Castagnoli, N; Van der Schyf, CJ
      Empirical and molecular modeling study of the pyridinium species RHPP+, anabundant and potentially neurotoxic metabolite of haloperidol

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
    64. Pagel, P; Schubert, R; Wolf, HU
      Development of a method for sample preparation for subsequent identification and measurement of 1,2,3,4-tetrahydroisoquinolines and other potentiallyneurotoxic compounds by high-performance liquid chromatography with ultraviolet and fluorescence detection in blood plasma of Parkinson's disease patients

      JOURNAL OF CHROMATOGRAPHY B
    65. Canudas, AM; Friguls, B; Planas, AM; Gabriel, C; Escubedo, E; Camarasa, J; Camins, A; Pallas, M
      MPP+ injection into rat substantia nigra causes secondary glial activationbut not cell death in the ipsilateral striatum

      NEUROBIOLOGY OF DISEASE
    66. Gearhart, DA; Collins, MA; Lee, JM; Neafsey, EJ
      Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease

      NEUROBIOLOGY OF DISEASE
    67. Howell, LL; Byrd, LD; McDonough, AM; Iuvone, PM; Bakay, RAE
      Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation

      CELL TRANSPLANTATION
    68. Klivenyi, P; Andreassen, OA; Ferrante, RJ; Lancelot, E; Reif, D; Beal, MF
      Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity

      NEUROREPORT
    69. Fredriksson, A; Palomo, T; Archer, T
      Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa

      BEHAVIOURAL PHARMACOLOGY
    70. Bezard, E; Jaber, M; Gonon, F; Boireau, A; Bloch, B; Gross, CE
      Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse

      EUROPEAN JOURNAL OF NEUROSCIENCE
    71. Fernandez-Gonzalez, A; Perez-Otano, I; Morgan, JI
      MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes

      EUROPEAN JOURNAL OF NEUROSCIENCE
    72. Bringmann, G; Feineis, D; God, R; Bruckner, R; Protzen, JA; Blank, M; Peters, K; Peters, EM; Janetzky, B; Reichmann, H
      Chemical modification of the mitochondrial complex I inhibitor 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: Synthesis and evaluation of N-alkanoyl derivatives

      ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    73. Schneider, JS; Rothblat, DS
      Differences in release and clearance of extracellular dopamine in the striatum after spontaneous or GM1-ganglioside-stimulated recovery from experimental Parkinsonism

      RESTORATIVE NEUROLOGY AND NEUROSCIENCE
    74. Przedborski, S; Jackson-Lewis, V; Djaldetti, R; Liberatore, G; Vila, M; Vukosavic, S; Almer, G
      The parkinsonian toxin MPTP: action and mechanism

      RESTORATIVE NEUROLOGY AND NEUROSCIENCE
    75. Lam, HR; Ladefoged, O; Ostergaard, G; O'Callaghan, JP
      Inhalation exposure to white spirit causes region-dependent alterations inthe levels of glial fibrillary acidic protein

      NEUROTOXICOLOGY AND TERATOLOGY
    76. Kilbourn, MR; Kuszpit, K; Sherman, P
      Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

      SYNAPSE
    77. Araki, T; Kumagai, T; Matsubara, M; Ido, T; Imai, Y; Itoyama, Y
      Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice

      METABOLIC BRAIN DISEASE
    78. Di Monte, DA; McCormack, A; Petzinger, G; Janson, AM; Quik, M; Langston, WJ
      Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model

      MOVEMENT DISORDERS
    79. Albin, RL
      Basal ganglia neurotoxins

      NEUROLOGIC CLINICS
    80. Kay, JN; Blum, M
      Differential response of ventral midbrain and striatal progenitor cells tolesions of the nigrostriatal dopaminergic projection

      DEVELOPMENTAL NEUROSCIENCE
    81. Fahn, S
      The spectrum of levodopa-induced dyskinesias

      ANNALS OF NEUROLOGY
    82. Langston, JW; Quik, M; Petzinger, G; Jakowec, M; Di Monte, DA
      Investigating levodopa-induced dyskinesias in the Parkinsonian primate

      ANNALS OF NEUROLOGY
    83. Nutt, JG
      Clinical pharmacology of levodopa-induced dyskinesia

      ANNALS OF NEUROLOGY
    84. Sapirstein, A; Bonventre, JV
      Phospholipases A(2) in ischemic and toxic brain injury

      NEUROCHEMICAL RESEARCH
    85. Rojas, P; Rojas-Castaneda, J; Vigueras, RM; Habeebu, SSM; Rojas, C; Rios, C; Ebadi, M
      MPTP decreases MT-I mRNA in mouse striatum

      NEUROCHEMICAL RESEARCH
    86. Marini, AM; Nowak, TS
      Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures

      JOURNAL OF NEUROSCIENCE RESEARCH
    87. Cochiolo, JA; Ehsanian, R; Bruck, DK
      Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons

      JOURNAL OF NEUROSCIENCE RESEARCH
    88. Forsyth, JT; Grunewald, RA; Rostami-Hodjegan, A; Lennard, MS; Sagar, HJ; Tucker, GT
      Parkinson's disease and CYP1A2 activity

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    89. Elsworth, JD; Taylor, JR; Sladek, JR; Collier, TJ; Redmond, DE; Roth, RH
      Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in Old-World primates one year after MPTP treatment

      NEUROSCIENCE
    90. Mogi, M; Togari, A; Tanaka, K; Ogawa, N; Ichinose, H; Nagatsu, T
      Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506

      NEUROSCIENCE LETTERS
    91. Annepu, J; Ravindranath, V
      1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced complex I inhibition is reversed by disulfide reductant, dithiothreitol in mouse brain

      NEUROSCIENCE LETTERS
    92. Zou, LL; Xu, J; Jankovic, J; He, Y; Appel, SH; Le, WD
      Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice

      NEUROSCIENCE LETTERS
    93. Xiao, AY; Double, K; Heinemann, T; Rausch, WD; Riederer, P; Gerlach, M
      The industrial chemical Tinuvin 123 does not induce dopaminergic neurotoxicity in C57BI/6 mice

      NEUROSCIENCE LETTERS
    94. Nicotra, A; Parvez, SH
      Cell death induced by MPTP, a substrate for monoamine oxidase B

      TOXICOLOGY
    95. Rojas, P; Hidalgo, J; Ebadi, M; Rios, C
      Changes of metallothionein I plus II proteins in the brain after 1-methyl-4-phenylpyridinium administration in mice

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    96. Dorman, DC
      An integrative approach to neurotoxicology

      TOXICOLOGIC PATHOLOGY
    97. Schmued, LC; Hopkins, KJ
      Fluoro-Jade: Novel fluorochromes for detecting toxicant-induced neuronal degeneration

      TOXICOLOGIC PATHOLOGY
    98. Frechilla, D; Insausti, R; Ruiz-Golvano, P; Garcia-Osta, A; Rubio, MP; Almendral, JM; Del Rio, J
      Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum

      MOLECULAR BRAIN RESEARCH
    99. Nicotra, A; Parvez, SH
      MPTP neurotoxins inducing cell death and a substrate for B form of enzyme monoamine oxidase

      BIOGENIC AMINES
    100. McGrew, DM; Irwin, I; Langston, JW
      Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice

      NEUROTOXICOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 11:10:10